Damsker, Jesse M.
Cornish, Michaelyn R.
Kanneboyina, Priya
Kanneboyina, Ila
Yu, Qing
Lipson, Rachel
Phadke, Aditi
Knoblach, Susan M.
Panchapakesan, Karuna
Morales, Melissa
Fiorillo, Alyson A.
Partridge, Terence
Nagaraju, Kanneboyina
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (1R41AR068816-01)
Article History
Received: 10 January 2019
Revised: 2 July 2019
Accepted: 19 August 2019
First Online: 24 August 2019
Compliance with ethical standards
:
: :JMD, MRC, RL, and KN are employed by ReveraGen BioPharma Inc. JMD has ReveraGen BioPharma Inc. stock options, and KN has ReveraGen BioPharma Inc. founder shares. AAF has a consulting agreement with ReveraGen BioPharma Inc.
: All procedures performed in studies involving animals were in accordance with the ethical standards of the Institutional Animal Care and Use Committee at Children’s National Health System.